Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Why pharma needs to take a leaf out of the auto sector’s book

23h thehindubusinessline
The pharmaceutical industry could well take a page out of the automobile industry’s book when it comes to handling attrition and quality, said Sun Pharmaceutical Managing Director Dilip Shanghvi. (2-0)

Here#39;s what Cadila has to say about US price erosion concerns

2018-02-23 moneycontrol
The Indian Pharmaceutical Alliance's (IPA) quality forum is currently underway in Hyderbad. CNBC-TV18’s Arachana Shukla caught up with the Managing Director of Cadila Healthcare, Sharvil Patel on the sidelines of that forum and asked him about price erosion in the US market. (2-0)

Sensex bounces back amid global recovery

2018-02-12 in.reuters
REUTERS - Indian shares rose on Monday, recovering from their biggest weekly drop since August, as a battered healthcare sector recouped, although State Bank of India slumped after posting a surprise quarterly loss. (3-0)

Market Update: Midcap index outshines; Tata Steel, ONGC jump 3-4%; Ashok Leyland hits new 52-week high, SBI falls 3%

2018-02-12 moneycontrol
A new week and a new start - it was a green opening from the Indian indices with the Sensex jumping over 256 points or 0.75 percent in early trade while the Nifty added 73 points or 0.72 percent. (26-0)

Pharma weekly wrap: Lupin, Glenmark post nos; Singh brothers resign from Fortis board

2018-02-10 moneycontrol
Pharma stocks recovered this past week after budget week lows, despite weakness of benchmark index. The investors took advantage of relatively cheap valuations of pharma shares. The highlights of the week include resignation of Malvinder and Shivinder Singh, promoters of Fortis, from the Board and Q3 results of some major pharmaceutical companies. With exception of Cadila Healthcare, Aurobindo Pharma and Cipla – the rest of pack had posted disappointing Q3 numbers as they struggled with pricing pressures in US market. (2-0)

Cadila Healthcare Limited - Press Release

2018-02-09 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (2-0)

Zydus Cadila sees 60% of topline from US by FY20 even as rivals lose share

2018-02-09 business-standard
Cadila Healthcare is having a dream run in the US, riding primarily on growth in base business coupled with a steady pipeline of launches lined up for that country. The contribution of the US in its overall turnover has been growing steadily at a time when most of its peers saw the share of US business shrink in their turnovers -- it grew from 43 per cent in the first quarter of the 2017-18 fiscal to 48 per cent now. (2-0)

Sensex hits triple century after 7-day losses; midcaps outshine, all sectoral indices up

2018-02-08 moneycontrol
Bulls were back in action on Thursday as the market snapped seven-day losing streak, with the benchmark indices clocking 1 percent gain and all sectoral indices ending in the green. Positive Asian cues and Brent crude futures trading at one-month low around USD 65 a barrel against USD 71 a barrel in January 2018 also boosted market sentiment. (9-0)

Closing Bell: Sensex gains 330 pts, Nifty fails to hold 10,600; pharma, cement stocks rally

2018-02-08 moneycontrol
The 30-share BSE Sensex was up 330.45 points or 0.97 percent at 34,413.16, and the 50-share NSE Nifty gained 100.20 points or 0.96 percent at 10,576.90. (16-0)

Market Live: Sensex off day#39;s high, up 300 pts, Nifty below 10,600; ACC up 4%

2018-02-08 moneycontrol
3:04 pm  Buyback: Balrampur Chini Mills said the meeting of the board of directors will be held on February 21, 2018, to consider a proposal for buy back of equity shares. The stock rallied 4 percent. (16-0)

Cadila Healthcare net profit zooms to Rs 306 cr

2018-02-08 thehindubusinessline
Total revenues of the company for the quarter ended December 2017 stood at Rs 1,632 crore against Rs 825 crore in the same quarter last year. (2-0)

Cadila Healthcare Limited - Financial Result Updates

2018-02-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (2-0)

Cadila Healthcare shares gain over 5% after strong Q3 performance on all parameters

2018-02-08 moneycontrol
Cadila Healthcare share price gained 5.5 percent intraday Thursday after showing strong performance on all fronts for October-December quarter. (2-0)

Cadila Healthcare Limited - Press Release

2018-02-08 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information. (2-0)

ABB, ACC, BHEL, SAIL results on Thursday

2018-02-07 thehindubusinessline
Close to 150 companies will declare their Q3 numbers on Thursday. Among these are ABB, ACC, Adlabs, Andhra Bank, Balrampur Chini, Bharat Forge, BHEL, Bombay Dyeing, Cadila Healthcare, CESC, Dhanlaxmi Bank, Dr Lal Path, Eros, Future Consumer, Glenmark, GSPL, GIPCL, HeidelbergCement, Manappuram Finance, Muthoot, Parag Mills, Reliance Capital, Religare, SAIL, SKF India, Talwalkars, Tata Communications, Trent and Welspun Corp. (7-0)


CUSIP: 006378905